Pharmadrug LMLLF Stock
Pharmadrug Price Chart
Pharmadrug LMLLF Financial and Trading Overview
Pharmadrug stock price | 0.0067 USD |
Previous Close | 0.007 USD |
Open | 0.0054 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.007 - 0.007 USD |
52 Week Range | 0.0041 - 0.03 USD |
Volume | 34.49K USD |
Avg. Volume | 51.36K USD |
Market Cap | 2.49M USD |
Beta (5Y Monthly) | 3.055428 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.16 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LMLLF Valuation Measures
Enterprise Value | 3.66M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.2916667 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -4.607 |
Trading Information
Pharmadrug Stock Price History
Beta (5Y Monthly) | 3.055428 |
52-Week Change | -72.54% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.03 USD |
52 Week Low | 0.0041 USD |
50-Day Moving Average | 0.0074654 USD |
200-Day Moving Average | 0.01 USD |
LMLLF Share Statistics
Avg. Volume (3 month) | 51.36K USD |
Avg. Daily Volume (10-Days) | 71.77K USD |
Shares Outstanding | 355.63M |
Float | 348.05M |
Short Ratio | N/A |
% Held by Insiders | 1.88% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -6.33% |
Return on Equity (ttm) | -13.58% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -795002 USD |
Net Income Avi to Common (ttm) | -1628192 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 220.62K USD |
Total Cash Per Share (mrq) | 0.001 USD |
Total Debt (mrq) | 1.39M USD |
Total Debt/Equity (mrq) | 16.11 USD |
Current Ratio (mrq) | 0.539 |
Book Value Per Share (mrq) | 0.024 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1096925 USD |
Levered Free Cash Flow (ttm) | -810520 USD |
Profile of Pharmadrug
Country | United States |
State | ON |
City | Toronto |
Address | 77 King Street West |
ZIP | M5K 1H1 |
Phone | N/A |
Website | https://www.pharmadrug.ca |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to vertically integrated elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of cepharanthine; and clinical trial agreement with Johns Hopkins University to conduct a clinical study comparing acute and enduring psychological and neural effects of DMT and an undisclosed potently active comparator molecule. Further, the company also holds interest in Sairiyo Therapeutics Inc. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug Inc. is based in Toronto, Canada.
Q&A For Pharmadrug Stock
What is a current LMLLF stock price?
Pharmadrug LMLLF stock price today per share is 0.0067 USD.
How to purchase Pharmadrug stock?
You can buy LMLLF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharmadrug?
The stock symbol or ticker of Pharmadrug is LMLLF.
Which industry does the Pharmadrug company belong to?
The Pharmadrug industry is Drug Manufacturers-Specialty & Generic.
How many shares does Pharmadrug have in circulation?
The max supply of Pharmadrug shares is 116.76M.
What is Pharmadrug Price to Earnings Ratio (PE Ratio)?
Pharmadrug PE Ratio is now.
What was Pharmadrug earnings per share over the trailing 12 months (TTM)?
Pharmadrug EPS is -0.16 USD over the trailing 12 months.
Which sector does the Pharmadrug company belong to?
The Pharmadrug sector is Healthcare.